Investigating the possible therapeutic effects of the homoeopathic remedy Apis Mellifica on Weaver Fish stings using a double blind randomised controlled trial

ISRCTN ISRCTN16880978
DOI https://doi.org/10.1186/ISRCTN16880978
Secondary identifying numbers 2005-005934-11
Submission date
21/12/2005
Registration date
21/12/2005
Last edited
06/09/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Mr David Retford
Scientific

Opie Building
Trevenson Road
Pool, Redruth
TR15 3RD
United Kingdom

Phone +44 (0)1209 617620
Email david.retford@cbs.ac.uk

Study information

Study designDouble Blind Randomised Controlled Trial (RCT)
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet No participant information sheet available
Scientific titleInvestigating the possible Therapeutic Effects of the Homoeopathic Remedy Apis Mellifica on Weaver Fish Stings using a Double Blind Randomised Controlled Trial
Study acronymWeaver-fish & Homoeopathy
Study objectivesThat homoeopathic apis mellificia will be more effective in treating the sting from a weaver fish than a placebo
Ethics approval(s)Informed consent: understanding spoken and written english, over the age of eighteen, or with parental guidance and consent if under 18. There will be written informed consent from all participants or parents where needed. Informed of data protection, and possible adverse reactions to the homoeopathic remedy. Openness and honesty: Double blind test, thus the participant might be given a placebo although they will still receive the standard treatment. Right to withdraw. Protection from possible harm. Debriefing. Confidentiality and to follow all ethical principals of relevent professional bodies.
Health condition(s) or problem(s) studiedSting from weaver fish
InterventionStandard treatment of feet submerged in hot water, plus homoeopathic remedy or placebo remedy
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Apis Mellifica
Primary outcome measurePain relief
Secondary outcome measuresRemoval of concomitant symptoms
Overall study start date01/03/2006
Completion date31/10/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexBoth
Target number of participants250
Key inclusion criteriaType 1, healthy clients, affected by weaver-fish sting, within one hour.
Key exclusion criteria1. Over 65 years of age
2. Unable to read english
3. Taking any prescribed medication
4. Not NHS registered
5. Have taken any previous form of treatment for the sting
6. Have been stung already this year
7. Any heart condition
8. Any other contraindications to treatment
Date of first enrolment01/03/2006
Date of final enrolment31/10/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Opie Building
Pool, Redruth
TR15 3RD
United Kingdom

Sponsor information

Cornwall College Camborne (UK)
University/education

Opie Building
Trevenson Road
Pool, Redruth
TR15 3RD
England
United Kingdom

Phone +44 (0)1209 617620
Email david.retford@cbs.ac.uk
Website http://www.cornwall.ac.uk/
ROR logo "ROR" https://ror.org/006pak935

Funders

Funder type

University/education

Cornwall College Camborne (UK)

No information available

Royal National Lifeboat Institution (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

06/09/2016: No publications found in PubMed, verifying study status with principal investigator.